ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 178 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $360,838,000 | -27.5% | 3,882,502 | -53.5% | 0.06% | -31.8% |
| Q3 2021 | $497,426,000 | -14.1% | 8,353,075 | -1.6% | 0.08% | -11.5% |
| Q2 2021 | $578,976,000 | +2.6% | 8,489,384 | +4.4% | 0.10% | -3.0% |
| Q1 2021 | $564,110,000 | +16.7% | 8,129,562 | +29.3% | 0.10% | +11.2% |
| Q4 2020 | $483,186,000 | +52.4% | 6,289,051 | +48.4% | 0.09% | +34.8% |
| Q3 2020 | $317,005,000 | +15.9% | 4,238,593 | -2.5% | 0.07% | +8.2% |
| Q2 2020 | $273,556,000 | +37.1% | 4,345,588 | -8.5% | 0.06% | +15.1% |
| Q1 2020 | $199,527,000 | -6.1% | 4,750,631 | +1.6% | 0.05% | +17.8% |
| Q4 2019 | $212,377,000 | -2.9% | 4,675,863 | -2.2% | 0.04% | -8.2% |
| Q3 2019 | $218,763,000 | -25.1% | 4,779,619 | -4.0% | 0.05% | -24.6% |
| Q2 2019 | $291,959,000 | +31.4% | 4,979,681 | +0.5% | 0.06% | +30.0% |
| Q1 2019 | $222,154,000 | +15.2% | 4,955,467 | +0.1% | 0.05% | +4.2% |
| Q4 2018 | $192,795,000 | -12.9% | 4,949,799 | +2.9% | 0.05% | +2.1% |
| Q3 2018 | $221,420,000 | +6.5% | 4,811,363 | +0.9% | 0.05% | +2.2% |
| Q2 2018 | $207,955,000 | +10.0% | 4,769,593 | -0.4% | 0.05% | +7.0% |
| Q1 2018 | $189,133,000 | +51.1% | 4,788,145 | +32.6% | 0.04% | +53.6% |
| Q4 2017 | $125,162,000 | +37.8% | 3,611,173 | +3.3% | 0.03% | +40.0% |
| Q3 2017 | $90,797,000 | +79.5% | 3,496,493 | +16.6% | 0.02% | +66.7% |
| Q2 2017 | $50,595,000 | – | 2,999,167 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $100 | 0.00% |